Reports Q2 revenue $240.678M, consensus $238.39M. “In the second quarter, we increased U.S. pump shipments while strengthening our business model and improving operational efficiency,” said John Sheridan, president and chief executive officer. “Looking at the remainder of the year, we are advancing our product development and commercial initiatives, which positions us well for sustained double-digit growth and enhanced profitability.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Notable companies reporting after market close
- Tandem Diabetes price target lowered to $38 from $48 at Leerink
- Tandem Diabetes downgraded to Sell from Neutral at Citi
- Wells says CBP proposal for CGMs expected, insulin pumps inclusion ‘a surprise’
- Diabetes device maker shares slide after payment scheduling proposal